To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...
Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...
An estimated 1 in 8 men will be diagnosed with prostate cancer in their lifetime, often after 65. And as terrifying as that number is, a diagnosis isn’t always quite what it seems. Today, the vast ...
Stage 1 prostate adenocarcinoma is localized, non-aggressive, and often detected through routine screenings like PSA tests and DREs. Diagnosis involves PSA levels, Gleason scores, and possibly ...
Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...
AMPLIFY: A phase 3 study of 64Cu-SAR-bisPSMA positron emission tomography in participants with biochemical recurrence of prostate cancer. SOLACE: A phase 1 pharmacokinetic, dosimetry, safety, and dose ...
Every two minutes, a man in the U.S. is diagnosed with prostate cancer. Every 15 minutes, another dies of it. Prostate cancer disproportionately affects Black men. In D.C., more die from prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results